Children with cancer during COVID‐19 pandemic: Early experience in Mexico
| Autor: | Rocío Cárdenas-Navarrete, Javier Enrique López-Aguilar, Jorge Alfonso Martín-Trejo, Alfredo Simental Toba, Gissel Soto-Pérez, Guadalupe Miranda-Novales, Patricia Thomé-Ortiz, Guillermo Vázquez-Rosales, Daniel Octavio Pacheco-Rosas |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Cancer Hematology medicine.disease Tertiary care Virology Test (assessment) Precursor Cell Lymphoblastic Leukemia Lymphoma Oncology Emergency medicine Pediatrics Perinatology and Child Health Pandemic Medicine Pulmonary hemorrhage Pediatrics Perinatology and Child Health business Mild disease Medical attention |
| Zdroj: | Pediatric Blood & Cancer |
| ISSN: | 1545-5017 1545-5009 |
| DOI: | 10.1002/pbc.28660 |
| Popis: | Reports of children with cancer and COVID-19 from U.S.A and Europe had informed most patients presented with mild disease. Experience from upper and lower middle-income countries is needed to corroborate these findings. This report describes the experience with cancer patients in a tertiary care level hospital, in Mexico City. Of 24 symptomatic patients, 14 had a positive RT-PCR test. Eight required low-flow supplemental oxygen. None required critical care. One patient died due to pulmonary hemorrhage. Even though the infection seems to have an uncomplicated clinical course, it is necessary to ensure that all seeking medical attention do so safely. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text